Insider screener

Period: 12 months Type of trade: Sold × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,718 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,718 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,718 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,718 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,718 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,718 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,718 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
27 Jul 2026
Murtagh Nigel J Chief Risk Officer
Sold on a plan 2×
$3.43M 32,947 at 104.01
36.2%
Planned (10b5-1)
27 Jul 2026
Russo Carl Director · indirect
Sold on a plan
$2.71M 75,000 at 36.20
4.6%
Planned (10b5-1)
27 Jul 2026
Ye Gang COO · indirect
Sold on a plan 3×
$2.07M 20,000 at 103.69
9.1%
Planned (10b5-1)
27 Jul 2026
Kurtz George PRESIDENT AND CEO
Sold on a plan 9×
$1.83M 10,000 at 183.41
0.1%
Planned (10b5-1)
27 Jul 2026
Bailo Karen Commercial Lines President
Sold on a plan
$1.80M 8,452 at 212.71
20.7%
Planned (10b5-1)
27 Jul 2026
Sold on a plan 6×
$1.79M 10,000 at 179.37
0.9%
Planned (10b5-1)
27 Jul 2026
Murphy John Jo Claims President
Sold on a plan
$1.73M 8,124 at 212.70
16.4%
Planned (10b5-1)
27 Jul 2026
ONeill Francis James Co-Founder, Chief U/W Officer · indirect
Sold on a plan
$1.62M 110,467 at 14.63
1.6%
Planned (10b5-1)
27 Jul 2026
RADKE JEFFREY L Co-Founder, CEO · indirect
Sold on a plan 2×
$1.39M 95,223 at 14.60
0.3%
Planned (10b5-1)
27 Jul 2026
PICKERING GRANT CHIEF EXECUTIVE OFFICER
Sold on a plan 2×
$901.07K 16,198 at 55.63
3.5%
Planned (10b5-1)
27 Jul 2026
Harvey Rory Executive Vice President
Sold on a plan
$772.29K 8,882 at 86.95
23.8%
Planned (10b5-1)
27 Jul 2026
Ghaffarian Kamal Seyed Director · indirect
Sold on a plan
$624.40K 47,303 at 13.20
1.3%
Planned (10b5-1)
27 Jul 2026
Blum Robert I President & CEO
Sold on a plan
$606.53K 7,500 at 80.87
1.9%
Planned (10b5-1)
27 Jul 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$570.47K 2,190 at 260.49
2.0%
Planned (10b5-1)
27 Jul 2026
Olivan Javier Chief Operating Officer
Sold on a plan
$508.77K 837 at 607.85
11.7%
Planned (10b5-1)
27 Jul 2026
Bauer Jonathan S. Chief Investment Officer
Sold on a plan
$476.90K 2,242 at 212.71
7.9%
Planned (10b5-1)
27 Jul 2026
Sold on a plan
$473.28K 6,000 at 78.88
0.4%
Planned (10b5-1)
27 Jul 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$447.52K 1,718 at 260.49
0.1%
Planned (10b5-1)
27 Jul 2026
Simon Amy Chief Medical Officer
Sold on a plan
$429.04K 16,667 at 25.74
16.3%
Planned (10b5-1)
27 Jul 2026
Olivan Javier Chief Operating Officer · indirect
Sold on a plan 4×
$382.34K 629 at 607.85
27.8%
Planned (10b5-1)
27 Jul 2026
Boyd William M III Chief Strategy Officer
Sold on a plan 2×
$377.36K 9,194 at 41.04
13.9%
Planned (10b5-1)
27 Jul 2026
Fendley Steven S. President, US Division
Sold on a plan 2×
$329.91K 7,000 at 47.13
2.3%
Planned (10b5-1)
27 Jul 2026
Bacos Anthony Chief Prod/Technology Officer
Sold on a plan 2×
$263.48K 70,000 at 3.76
6.7%
Planned (10b5-1)
27 Jul 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$263.10K 1,010 at 260.49
0.8%
Planned (10b5-1)
27 Jul 2026
Sternberg Matthew David COO, Risk Exchange
Sold on a plan
$257.21K 17,568 at 14.64
2.9%
Planned (10b5-1)
27 Jul 2026
Sold on a plan 2×
$235.78K 9,372 at 25.16
0.1%
Planned (10b5-1)
27 Jul 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$230.27K 884 at 260.49
0.5%
Planned (10b5-1)
27 Jul 2026
Pettiti Gianluca President & COO
Sold on a plan
$226.00K 400 at 565.00
1.6%
Planned (10b5-1)
27 Jul 2026
DUCHENE TODD M See remarks
Sold on a plan 3×
$209.48K 10,000 at 20.95
0.5%
Planned (10b5-1)
27 Jul 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$203.70K 782 at 260.49
1.4%
Planned (10b5-1)
27 Jul 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$203.70K 782 at 260.49
0.4%
Planned (10b5-1)
27 Jul 2026
Rosenbaum Michael George Chief Executive Officer
Sold on a plan
$170.77K 1,200 at 142.31
0.6%
Planned (10b5-1)
27 Jul 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan 2×
$150.16K 6,214 at 24.16
22.4%
Planned (10b5-1)
27 Jul 2026
Boyle Dana Chief Accounting Officer
Sold on a plan
$140.05K 1,600 at 87.53
0.9%
Planned (10b5-1)
27 Jul 2026
Eltoukhy Adam SEE REMARKS
Sold on a plan 2×
$127.66K 3,653 at 34.95
0.9%
Planned (10b5-1)
27 Jul 2026
Wang Yanjun CCO and GC · indirect
Sold on a plan 3×
$124.90K 1,200 at 104.08
4.7%
Planned (10b5-1)
27 Jul 2026
PICKERING GRANT CHIEF EXECUTIVE OFFICER · indirect
Sold on a plan 4×
$111.31K 2,000 at 55.65
1.5%
Planned (10b5-1)
27 Jul 2026
Nonko Eugene Director · indirect
Sold on a plan
$108.93K 8,205 at 13.28
0.8%
Planned (10b5-1)
27 Jul 2026
Ceesay Abraham Chief Executive Officer
Sold on a plan 2×
$93.06K 2,210 at 42.11
0.4%
Planned (10b5-1)
27 Jul 2026
Briggs Andrew J Director
Sold on a plan
$92.94K 3,000 at 30.98
3.0%
Planned (10b5-1)
27 Jul 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer · indirect
Sold on a plan 12×
$87.52K 3,622 at 24.16
23.5%
Planned (10b5-1)
27 Jul 2026
Lewis Michael A Director
Sold on a plan
$79.66K 1,537 at 51.83
9.3%
Planned (10b5-1)
27 Jul 2026
Sheena Jonathan Director
Sold on a plan
$75.02K 288 at 260.49
0.1%
Planned (10b5-1)
27 Jul 2026
RUBIN KEVIN Chief Financial Officer
Sold on a plan 5×
$74.00K 503 at 147.12
1.2%
Planned (10b5-1)
27 Jul 2026
Blouin Ann Scott Director
Sold on a plan 2×
$68.83K 375 at 183.54
1.6%
Planned (10b5-1)
27 Jul 2026
Adair Jason Chief Business Officer
Sold on a plan
$60.22K 688 at 87.53
0.3%
Planned (10b5-1)
27 Jul 2026
Nonko Eugene Director
Sold on a plan
$43.57K 3,282 at 13.28
0.4%
Planned (10b5-1)
27 Jul 2026
Gupta Vikram See Remarks
Sold on a plan
$41.11K 360 at 114.20
0.4%
Planned (10b5-1)
27 Jul 2026
Shachar Erez Director · indirect
Sold on a plan
$29.34K 5,586 at 5.25
0.5%
Planned (10b5-1)
27 Jul 2026
Menu Philippe Chief Medical Officer
Sold on a plan
$28.31K 5,000 at 5.66
2.2%
Planned (10b5-1)
Showing 5,301–5,350 of 22,718. ← Newer Page 107 of 455 Older →